Overall rank by patents
#26,900
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
Molecula holds 10 US patents across 6 technology areas, rank #26,900 of 50,000 tracked assignees.
Molecula Corp. has been granted 10 US utility patents between 2020 and 2024, placing Molecula Corp. at rank #26,900 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a US Corporation, Molecula Corp. is one of the more focused assignees in the PatentsView dataset. By volume, Molecula sits between Mizuho Orthopedic Systems, Inc. (10 patents, rank #26,896) and Morgan Advanced Ceramics, Inc. (10 patents, rank #26,904) - the closest US assignees by grant volume. The composite Innovation Score of 44.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Molecula Corp.'s 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Molecula Corp. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mizuho Orthopedic Systems, Inc.
10 patents
Mochii, Inc.
10 patents
Model N, Inc.
10 patents
Mohawk Industries, Inc.
10 patents
Momentum Dynamics Corporation
10 patents
Monell Chemical Senses Center
10 patents
Mores, Inc.
10 patents
Morgan Advanced Ceramics, Inc.
10 patents
Molecula Corp.
10 patents
What this shows Molecula holds 10 patents at rank #26,900, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,900 in granted patent volume.
Other assignees with the most granted patents in Molecula's primary technology class.
Molecula's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 20.0% |
| 2021 | 1 | 10.0% |
| 2022 | 2 | 20.0% |
| 2023 | 2 | 20.0% |
| 2024 | 3 | 30.0% |
Top 6 of 6 technology areas
Overall rank by patents
#26,900
Across all tracked assignees
44.0 out of 100
How to use this portfolio
Molecula's 10 grants land it in the top 27% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.